You searched for "genetic"
Hospital wins funding to investigate sickle cell sight loss.
The hospital trust is the first in the UK to lead on a research project to understand the impact of sickle cell disease on eyesight.Optometry Today’s new education resource for practice teams
Optometry Today (OT) has released a new education package for optometry practice teams, delivered in partnership with the Association of Optometrists (AOP) and Johnson & Johnson Vision.Early bird bookings are open for Optometry Tomorrow 2024 – now incorporating BCLA Focus
Taking place from 28-29 April 2024, at the Telford International Centre, the flagship conference of The College of Optometrists now incorporates the biennial UK conference of the British Contact Lens Association.New AOP members elected to join Hospital Optometrists Committee
The appointment of Lucy Andrews and Claire Melvin confirmed at the AOP’s Hospital and Specialty Optometrists Conference.
A scoping review of artificial intelligence tools for diabetic retinopathy in low- and middle-income countries
The authors conducted a scoping review to summarise the literature relating to artificial intelligence (AI) tools for diabetic retinopathy (DR) in low- and middle-income countries (LMICs). Eighty-one studies were included, following a comprehensive literature search. The majority of studies were...CHEC treats first surgical eye patients at REAL Battersea clinic
Community healthcare provider restores sight for local residents in partnership with the NHS.ABDO launches annual plan for 2024
The Association of British Dispensing Opticians (ABDO) has launched its new annual plan, which will guide its work over the coming year on behalf of members.
Intravitreal triamcinolone for uveitic macular oedema
This paper from South Korea reports on a prospective, double blind, randomised clinical study designed to evaluate the additional benefit of intravitreal triamcinolone (TA) administration for noninfectious uveitic macular oedema as an adjunct therapy to systemic anti-inflammatory treatment. Patients were...
A phase 3 randomised trial of nicotinamide for skin cancer chemoprevention
To B3, or not to B3? That was the question asked in this controlled trial in which the authors were able to show that oral nicotinamide (vitamin B3) is able to reduce further skin cancer development in high risk patients....
Intravitreal dexamethasone implant for diabetic macular oedema
The authors report on the three-year outcomes of the Ozurdex Dexamethasone (DEX) intravitreal implant multi-centre trial for the treatment of diabetic macular oedema (DME). Patients with DME (best-corrected vision of 20/50 to 20/200 and central retinal thickness of ≥300µm) were...
